Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
RDY
— Dr. Reddy's Laboratories Limited
NYSE
FULL STOCK PAGE →
Q4 2026 Earnings Call Summary
MAY 12, 2026
REVENUE
$76.33B
-12.5%
NET MARGIN
2.9%
-10.9 PTS
EPS
$2.68
-81.6%
FREE CASH FLOW
$10.75B
+199.6%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →